Shypd.aiThe largest open index of AI tools[RE]MEDs is a Pharma & Biotech tool that leverages AI to identify new cures for diseases by studying thousands of drugs in-silico. It primarily focuses on autoimmune disorders using electronic medical records and health datasets.
Trending
About
[RE]MEDs is an AI-powered platform dedicated to the real-life repurposing and repositioning of medicines, with a primary focus on autoimmune disorders. The platform utilizes a unique AI-powered technology to study thousands of drugs in-silico, analyzing billions of electronic medical records and health datasets. This advanced approach aims to identify new cures for diseases with unmet medical needs, particularly within the autoimmune space, which affects over 100 million people globally. [RE]MEDs investigates the effects of the vast majority of drugs (99%) that are not specifically designed for autoimmune diseases but are still used by patients, seeking to understand their impact and potentially discover new therapeutic applications. The research covers a wide range of autoimmune conditions including Systemic Lupus, Multiple Sclerosis, Rheumatoid Arthritis, and Type 1 Diabetes Mellitus.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check re-meds.com for current pricing.
FAQs
Trending
